This site is intended for U.S. healthcare professionals.
Menu
Close
Menu
Close
Adults aged 65 or older, including those with preexisting, stable medical conditions.
Study 1
Pneumococcal vaccine-naïve adults aged 18 or older1,5†
Study 3
3-lot consistency trial in adults aged 18 to 491,6
Study 6
Previously vaccinated adults aged 65 or older1,7
†Approximately one-third of participants in this study had risk factors that placed them at increased risk for serious pneumococcal disease.
Adults aged 65 or older with CAP and pneumococcal vaccination history confirmed by electronic health records.
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2025 Pfizer Inc. All rights reserved.